# Virtual Reality to Reduce Delirium

> **NCT04498585** · NA · SUSPENDED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 920 (estimated)

## Conditions studied

- Delirium
- Cognitive Impairment

## Interventions

- **OTHER:** VR Stimulation

## Key facts

- **NCT ID:** NCT04498585
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2021-04-14
- **Primary completion:** 2023-06
- **Final completion:** 2023-06
- **Target enrollment:** 920 (ESTIMATED)
- **Why stopped:** Decreased resources due to COVID-19
- **Last updated:** 2023-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04498585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04498585, "Virtual Reality to Reduce Delirium". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04498585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*